Publications

Zuccato, C., Marullo, M., Vitali, B., Tarditi, A., Mariotti, C., Valenza, M., Lahiri, N., Wild, E., Sassone, J., Ciammola, A., Bachoud-Levi, A., Tabrizi, S., Di Donato, S. & Cattaneo, E. (2011). Brain-derived neurotrophic factor in patients with Huntington's disease. PloS one, 6(8), e22966. doi:10.1371/journal.pone.0022966

Youssov, K., Dolbeau, G., Maison, P., Boissé, M., Cleret de Langavant, L., Roos, R. & Bachoud-Levi, A. (2013). The unified Huntington's Disease Rating Scale for advanced patients: validation and follow-up study. Movement disorders : official journal of the Movement Disorder Society, 28(14), 1995-2001. doi:10.1002/mds.25678

Woodgate, S. , Morgan-Jones, P. , Clinch, S. , Drew, C. , Playle, R. , Bennasar, M. , Hicks, Y. , Holt, C. , Bachoud-Levi, A., Massart, R., Craufurd, D., Kirby, N. , Hamana, K. , Schubert, R. , Reilmann, R., Rosser, A. & Busse, M. (2021). Objectively characterizing Huntington’s disease using a novel upper limb dexterity test. Journal of Neurology, 268, 2550-2559. doi:10.1007/s00415-020-10375-8

Witjes-Ané, M., Mertens, B., Van Vugt, J., Bachoud-Levi, A., Van Ommen, G. & Roos, R. (2007). Longitudinal evaluation of "presymptomatic" carriers of Huntington's disease. The Journal of neuropsychiatry and clinical neurosciences, 19(3), 310-7. doi:10.1176/jnp.2007.19.3.310

Wimberley, C., Lavisse, S., Brulon, V., Peyronneau, M., Leroy, C., Bodini, B., Remy, P., Stankoff, B., Buvat, I. & Bottlaender, M. (2018). Impact of Endothelial 18-kDa Translocator Protein on the Quantification of 18F-DPA-714. J Nucl Med, 59(2), 307-314. doi:10.2967/jnumed.117.195396

Wimberley, C., Lavisse, S., Brulon, V., Peyronneau, M., Kuhnast, B., Leroy, C., Remy, P., Stankoff, B. & Bottlaender, M. (2018). Impact of endothelial TSPO on the quantification of 18F-DPA714 in the normal human brain. , 59(2), 307-314. doi:10.2967/jnumed.117.195396

Wimberley, C., Lavisse, S., Brulon, V., Peyronneau, M., Leroy, C., Bodini, B., Remy, P., Stankoff, B., Buvat, I. & Bottlaender, M. (2017). Impact of endothelial TSPO on the quantification of 18F-DPA-714. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. doi:10.2967/jnumed.117.195396

Whone, A., Bailey, D., Remy, P., Pavese, N. & Brooks, D. (2004). A technique for standardized central analysis of 6-(18)F-fluoro-L-DOPA PET data from a multicenter study. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 45(7), 1135-45.

Whone, A., Watts, R., Stoessl, A., Davis, M., Reske, S., Nahmias, C., Lang, A., Rascol, O., Ribeiro, M., Remy, P., Poewe, W., Hauser, R., Brooks, D. & Real-Pet Study, G. (2003). Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study. Annals of neurology, 54(1), 93-101. doi:10.1002/ana.10609

Vittori, A., Orth, M., Roos, R., Outeiro, T., Giorgini, F., Hollox, E., Bachoud-Levi, A. & Registry Investigators Of The European Huntington’s Disease, N. (2013). β-defensin genomic copy number does not influence the age of onset in huntington’s disease. Journal of Huntington's Disease, 2(1), 107-124. doi:10.3233/JHD-130047

Visser, E., Keuken, M., Douaud, G., Gaura, V., Bachoud-Levi, A., Remy, P., Forstmann, B. & Jenkinson, M. (2016). Automatic segmentation of the striatum and globus pallidus using MIST: Multimodal Image Segmentation Tool. NeuroImage, 125, 479-497. doi:10.1016/j.neuroimage.2015.10.013

Villafane, G., Thiriez, C., Audureau, E., Straczek , C., Kerschen, P., Cormier-Dequaire , F., Van Der Gucht, A., Gurruchaga, J., Evangelista, E., Defer, G., Damier, P., Remy, P., Itti, E., Fenelon, G. & Quéré-Carne M, M. (2017). High-dose transdermal nicotine in Parkinson's disease patients: a randomized, open-label, blinded-endpoint evaluation phase 2 study. Eur J Neurol , 25, 120-127. doi:10.1111/ene.13474

Verny, C., Bachoud-Levi, A., Durr, A., Goizet, C., Azulay, J., Simonin, C., Tranchant, C., Calvas, F., Krystkowiak, P., Charles, P., Youssov, K., Scherer, C., Prundean, A., Olivier, A., Reynier, P., Saudou, F., Maison, P., Allain, P., Von Studnitz, E., Bonneau, D. & CYST-HD Study Group, . (2017). A randomized, Double-Blind, placebo-controlled trial evaluating cystéamine in Huntington’s disease. Mov. Disord., 32(6), 932-936

Verny, C., Bachoud-Levi, A., Durr, A., Goizet, C., Azulay, J., Simonin, C., Tranchant, C., Calvas, F., Krystkowiak, P., Charles, P., Youssov, K., Scherer, C., Prundean, A., Olivier, A., Reynier, P., Saudou, F., Maison, P., Allain, P., Von Studnitz, E., Bonneau, D. & Cyst-Hd Study, G. (2017). A randomized, double-blind, placebo-controlled trial evaluating cysteamine in Huntington's disease. Movement disorders : official journal of the Movement Disorder Society, 32(6), 932-936. doi:10.1002/mds.27010

Varani, K., Bachoud-Levi, A., Mariotti, C., Tarditi, A., Abbracchio, M., Gasperi, V., Borea, P., Dolbeau, G., Gellera, C., Solari, A., Rosser, A., Naji, J., Handley, O., Maccarrone, M., Peschanski, M., Didonato, S. & Cattaneo, E. (2007). Biological abnormalities of peripheral A2A receptors in a large representation of polyglutamine disorders and Huntington's disease stages. Neurobiology of Disease, 27(1), 36-43. doi:10.1016/j.nbd.2007.03.011

Vandendriessche, C., Bastian, M., Peyre, H., Stordeur, C., Asquaviva, E., Bahadori, S., Delorme, R. & Sackur, J. (2017). Attentional Lapses in Attention-Deficit/Hyperactivity Disorder: Blank Rather Than Wandering Thoughts. Psychological Science, 28(10), 1375-1386. doi:10.1177/0956797617708234

Van Der Gucht, A., Cleret de Langavant, L., Bélissant, O., Rabu, C., Cottereau, A., Evangelista, E., Chalaye, J., Bonnot-Lours, S., Fenelon, G. & Itti, E. (2016). Brain (18)F-FDG, (18)F-Florbetaben PET/CT, (123)I-FP-CIT SPECT and Cardiac (123)I-MIBG Imaging for Diagnosis of a "Cerebral Type" of Lewy Body Disease. Nuclear medicine and molecular imaging, 50(3), 258-60. doi:10.1007/s13139-016-0394-0

Van Der Gucht, A., Aoun Sebaiti, M., Guedj, E., Aouizerate, J., Yara, S., Gherardi, R., Evangelista, E., Chalaye, J., Cottereau, A., Verger, A., Bachoud-Levi, A., Abulizi, M., Itti, E. & Authier, F. (2017). Brain 18F-FDG PET Metabolic Abnormalities in Patients with Long-Lasting Macrophagic Myofascitis. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 58(3), 492-498. doi:10.2967/jnumed.114.151878

Van Der Gucht, A., Aoun-Sebaiti, M., Kauv, P., Guedj, E., Aouizerate, J., Verger, A., Gherardi, R., Bachoud-Levi, A., Authier, F. & Itti, E. (2016). FDG-PET/CT Brain Findings in a Patient With Macrophagic Myofasciitis. Nuclear medicine and molecular imaging, 50(1), 80-4. doi:10.1007/s13139-015-0371-z

Van Der Gucht, A., Aoun Sebaiti, M., Itti, E., Aouizerate, J., Evangelista, E., Chalaye, J., Gherardi, R., Ragunathan-Thangarajah, N., Bachoud-Levi, A. & Authier, F. (2015). Neuropsychological Correlates of Brain Perfusion SPECT in Patients with Macrophagic Myofasciitis. PloS one, 10(6), e0128353. doi:10.1371/journal.pone.0128353

Vaccarino, A., Sills, T., Anderson, K., Bachoud-Levi, A., Borowsky, B., Craufurd, D., Duff, K., Giuliano, J., Groves, M., Guttman, M., Kupchak, P., Ho, A., Paulsen, J., Pedersen, K., Van Duijn, E., Van Kammen, D. & Evans, K. (2011). Assessment of depression, anxiety and apathy in prodromal and early huntington disease. PLoS currents, 3, RRN1242. doi:10.1371/currents.RRN1242

Trinkler, I., Devignevielle, S., Achaibou, A., Ligneul, R., Brugières, P., Cleret de Langavant, L., De Gelder, B., Scahill, R., Schwartz, S. & Bachoud-Levi, A. (2017). Embodied emotion impairment in Huntington's Disease. Cortex; a journal devoted to the study of the nervous system and behavior, 92, 44-56. doi:10.1016/j.cortex.2017.02.019

Trinkler, I., Cleret de Langavant, L. & Bachoud-Levi, A. (2013). Joint recognition-expression impairment of facial emotions in Huntington's disease despite intact understanding of feelings. Cortex; a journal devoted to the study of the nervous system and behavior, 49(2), 549-58. doi:10.1016/j.cortex.2011.12.003

Traykov, L., Raoux, N., Latour, F., Gallo, L., Hanon, O., Baudic, S., Bayle, C., Wenisch, E., Remy, P. & Rigaud, A. (2007). Executive functions deficit in mild cognitive impairment. Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology, 20(4), 219-24. doi:10.1097/WNN.0b013e31815e6254

Titeux, H., Riad, R., Cao, X., Hamilakis, N., Madden, K., Cristia, A., Bachoud-Levi, A. & Dupoux, E. (2020). Seshat: A tool for managing and verifying annotation campaigns of audio data. In LREC - 2th Language Resources and Evaluation Conference, Marseille, France.

Thobois, S., Ribeiro, M., Lohmann, E., Durr, A., Pollak, P., Rascol, O., Guillouet, S., Chapoy, E., Costes, N., Agid, Y., Remy, P., Brice, A., Broussolle, E. & French Parkinson'S Disease Genetics Study, G. (2003). Young-onset Parkinson disease with and without parkin gene mutations: a fluorodopa F 18 positron emission tomography study. Archives of neurology, 60(5), 713-8. doi:10.1001/archneur.60.5.713

Thiriez, C., Itti, E., Fenelon, G., Evangelista, E., Meignan, M., Cesaro, P. & Remy, P. (2015). Clinical routine use of dopamine transporter imaging in 516 consecutive patients. Journal of neurology, 262(4), 909-15. doi:10.1007/s00415-014-7634-y

Thiriez, C., Villafane, G., Grapin, F., Fenelon, G., Remy, P. & Cesaro, P. (2011). Can nicotine be used medicinally in Parkinson's disease? Expert review of clinical pharmacology, 4(4), 429-36. doi:10.1586/ecp.11.27

Teichmann, M., Gaura, V., Démonet, J., Supiot, F., Delliaux, M., Verny, C., Renou, P., Remy, P. & Bachoud-Levi, A. (2008). Language processing within the striatum: evidence from a PET correlation study in Huntington's disease. Brain : a journal of neurology, 131(Pt 4), 1046-56. doi:10.1093/brain/awn036

Teichmann, M., Rosso, C., Martini, J., Bloch, I., Brugières, P., Duffau, H., Lehericy, S. & Bachoud-Levi, A. (2015). A cortical-subcortical syntax pathway linking Broca's area and the striatum. Human brain mapping, 36(6), 2270-83. doi:10.1002/hbm.22769